AbbVie commits $1.4B to NC plant in its largest-ever single campus investment

The Durham plant will manufacture immunology, neuroscience and oncology drugs once AbbVie finishes construction in 2028.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top